Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
BioVaxys Technology Corp.
C.BIOV
Alternate Symbol(s):
BVAXF
BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical...
-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:BIOV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(10)
•••
TheWeakendz
X
View Profile
View Bullboard History
Post by
TheWeakendz
on Mar 11, 2022 4:02pm
Let's see who dumped into 0.115
Waiting for ceo.ca to update.
(10)
•••
TheWeakendz
X
View Profile
View Bullboard History
Post by
TheWeakendz
on Mar 11, 2022 11:33am
Anonymous dumping hard
Ring a bell????????
(10)
•••
TheWeakendz
X
View Profile
View Bullboard History
Post by
TheWeakendz
on Mar 11, 2022 10:54am
Keep your eyes on the short report
If it increases, enjoy your toast for breakfast. Lol.
(10)
•••
TheWeakendz
X
View Profile
View Bullboard History
Post by
TheWeakendz
on Mar 10, 2022 10:40pm
On the bright side, we are 1300% above a penny
Will this bite the dust. I anticipate that it could. But I also anticipate $5.00 by the summer of 2023. We wish for success to help save lives. The Golden key could be if we hear the companies name on
...more
(10)
•••
ecanadian2
X
View Profile
View Bullboard History
Post by
ecanadian2
on Mar 10, 2022 1:38am
question for frankman or sb else:
Do you know what has been causing the share price erosion after the recent financing? Actually, the chart shows steady decline in share price over the last 6 mohths. They need significant
...more
(376)
•••
moneywagon
X
View Profile
View Bullboard History
Post by
moneywagon
on Mar 01, 2022 12:04pm
BIOV CATCH UP ON T-CELL ACTIVATING IMMUNOTHERAPY
by @newswire on 1 Mar 2022, 03:30 Long term study confirms efficacy of ISA Pharmaceuticals' T-cell activating immunotherapy in combination with checkpoint inhibitor
...more
(23)
•••
terryow
X
View Profile
View Bullboard History
Post by
terryow
on Mar 01, 2022 11:49am
Bid and ask
Ask 0.20 5,000 1 0.195 7,000 2 0.19 5,000 1 0.18 5,000 1 0.175
...more
(2805)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Mar 01, 2022 10:12am
Year end financials on SEDAR
They just raised $800k in addition to any current cash.
(2805)
•••
frankman
X
View Profile
View Bullboard History
Comment by
frankman
on Feb 28, 2022 8:32am
RE:BIOV CLOSES FINAL TRANCHE OF NON-BROKERED PVT PLACEMENT
Funding in place.
(76)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Feb 28, 2022 8:18am
BIOV CLOSES FINAL TRANCHE OF NON-BROKERED PVT PLACEMENT
BioVaxys Closes Final Tranche of Non-brokered Private Placement by @newswire on 28 Feb 2022, 08:00 VANCOUVER, BC, Feb. 28, 2022 /CNW/ -- BioVaxys Technology
...more
(376)
•••
moneywagon
X
View Profile
View Bullboard History
Post by
moneywagon
on Feb 27, 2022 7:54am
SEC UPDATES SHORT SELLING & CAT AMENDMENTS! WHY SO LATE SEC?
SEC Proposes Short Sale Disclosure Rule, Order Marking Requirement, and CAT Amendments Agency Also Reopens Comment Period for Proposed
...more
(376)
•••
moneywagon
X
View Profile
View Bullboard History
Post by
moneywagon
on Feb 18, 2022 10:45am
BIOV DOES THE MARKET DECIMATE THOSE@19-@195 SHARES TODAY?
hmmmmmmm SHOW ME @19!!! LET'S GO BEARS FEED DA BID and move outta da way...LONGS ARE ROARING FOR @20'S!!!$$$$$$$
(376)
•••
moneywagon
X
View Profile
View Bullboard History
Post by
moneywagon
on Feb 18, 2022 8:27am
GOOD MORNING BIOV REMEMBER CA MARKETS ARE CLOSED ON MONDAY
Schedule......If you are watching day screen trades, Brokers don't like to window dress over the weekend. (hold shares) That makes it a perfect day for CANADIANS TO BUY. This is 3 day weekend so
...more
(7)
•••
jeffa30
X
View Profile
View Bullboard History
Comment by
jeffa30
on Feb 17, 2022 11:18am
RE:CEO insider buying
https://www.canadianinsider.com/node/7?menu_tickersearch=BIOV+%7C+BioVaxys+Technology
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Xcyte Digital Corp. Releases "Xperience" Subscription Service
Drilling Approval Received for New Mexico Lithium Project
GameSquare Announces Formation of FaZe Media, Backed by $11M Investment